Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

Clinical trial NCT00454909 · COMPLETED

Trial details

NCT number: NCT00454909
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Meningococcal

Start date: 2007-04-23
Primary completion: 2007-10-31
Enrollment: 873

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.